VedTechBio Unveils Next-Gen Drug Discovery AI; Partners with AlphaMeld in Multi-Therapy Collaboration
By asianet
BENGALURU, India, Jul.31, 2025 /Globe Newswire-AsiaNet/– VedTechBio Research Pvt. Ltd., a pioneer in AI-driven drug discovery, today announced major enhancements to its RxAgentAI™ platform cutting drug discovery timelines in half alongside a strategic collaboration with AlphaMeld Corporation to co-develop multiple therapies for metabolic and rare diseases. RxAgentAI is an autonomous, multi-agentic intelligence system augmented by … Continued